The total fat from approximately 1mL of plasma was extracted in 97% hexane 3% diethyl ether solution by shake-solvent extraction. The extracted fat was then passed through two acid silica columns topped with sodium sulfate (first 20% and then 30% H2SO4) to remove matrix components. The purified extracts were evaporated under nitrogen and re-dissolved in 8μL of dimethyl sulfoxide (DMSO). The CALUX® cells were cultured in α-MEM culture medium supplemented with 10% (v/v) FCS under standard conditions (37°C, 5% CO2, 100% humidity) and were exposed in triplicate to cleaned extracts for 24 hours in 96-well microtiter plates. After incubation, the cells were lysed. A luciferine containing solution was added and the luciferase activity was measured using a luminometer. Each 96-well microtiter plate contained a 2,3,7,8-TCDD calibration range (0-3 pM 2,3,7,8-TCDD per well), a DMSO control, a procedure blank and an internal reference material. Total DR CALUX®-TEQ in the samples was determined by interpolation from the fitted 2,3,7,8-TCDD calibration curve and corrected for procedure blank. The limit of detection (LOD) was calculated as the signal measured from the DMSO control on each plate plus three times its standard deviation. Lipid content of the plasma was determined gravimetrically.
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Materials and Methods
Protocol for the DR CALUX bioassay
The total fat from approximately 1mL of plasma was extracted in 97% hexane 3% diethyl ether solution by shake-solvent extraction. The extracted fat was then passed through two acid silica columns topped with sodium sulfate (first 20% and then 30% H2SO4) to remove matrix components. The purified extracts were evaporated under nitrogen and re-dissolved in 8μL of dimethyl sulfoxide (DMSO). The CALUX® cells were cultured in α-MEM culture medium supplemented with 10% (v/v) FCS under standard conditions (37°C, 5% CO2, 100% humidity) and were exposed in triplicate to cleaned extracts for 24 hours in 96-well microtiter plates. After incubation, the cells were lysed. A luciferine containing solution was added and the luciferase activity was measured using a luminometer. Each 96-well microtiter plate contained a 2,3,7,8-TCDD calibration range (0-3 pM 2,3,7,8-TCDD per well), a DMSO control, a procedure blank and an internal reference material. Total DR CALUX®-TEQ in the samples was determined by interpolation from the fitted 2,3,7,8-TCDD calibration curve and corrected for procedure blank. The limit of detection (LOD) was calculated as the signal measured from the DMSO control on each plate plus three times its standard deviation. Lipid content of the plasma was determined gravimetrically. Table S1 . Associations between a 10 pg increase in maternal DR CALUX®-TEQ/g lipid and anogenital distances in newborn and young girls. 
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